Diana F. Hausman - 13 Jun 2025 Form 4 Insider Report for Immuneering Corp (IMRX)

Role
Director
Signature
/s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman
Issuer symbol
IMRX
Transactions as of
13 Jun 2025
Net transactions value
$0
Form type
4
Filing time
16 Jun 2025, 09:21:28 UTC
Previous filing
13 Jun 2024
Next filing
07 Jul 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
HAUSMAN DIANA Director 245 MAIN STREET, 2ND FLOOR, CAMBRIDGE /s/ Michael D. Bookman, Attorney-in-Fact for Diana F. Hausman 16 Jun 2025 0001563992

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IMRX Stock Option Award $0 +33,350 $0.000000 33,350 13 Jun 2025 Class A Common Stock 33,350 $1.90 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests and becomes exercisable in equal monthly installments over a one-year period commencing on July 13, 2025, and will be fully vested and exercisable on June 13, 2026, or the date of the 2026 annual meeting of stockholders, whichever comes first.